Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CG Oncology (CGON) Current Assets: 2023-2024

Historic Current Assets for CG Oncology (CGON) over the last 2 years, with Dec 2024 value amounting to $754.2 million.

  • CG Oncology's Current Assets rose 26.03% to $695.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $695.8 million, marking a year-over-year increase of 26.03%. This contributed to the annual value of $754.2 million for FY2024, which is 288.52% up from last year.
  • According to the latest figures from FY2024, CG Oncology's Current Assets is $754.2 million, which was up 288.52% from $194.1 million recorded in FY2023.
  • In the past 5 years, CG Oncology's Current Assets ranged from a high of $754.2 million in FY2024 and a low of $194.1 million during FY2023.
  • Its 2-year average for Current Assets is $474.2 million, with a median of $474.2 million in 2023.
  • Data for CG Oncology's Current Assets shows a peak YoY soared of 288.52% (in 2024) over the last 5 years.
  • CG Oncology's Current Assets (Yearly) stood at $194.1 million in 2023, then skyrocketed by 288.52% to $754.2 million in 2024.